Kurasiteku, a Tokyo, Japan–based company that provides AI agents specialized for the medical and nursing care industry, has secured funding.
Investors
The round was backed by Rice Capital, a venture capital firm based in Covina, California, founded in 2024, that invests in early-stage startups. The firm focuses on funding companies from seed to Series B stages, primarily in the United States and Japan, and supports startups across sectors such as technology and emerging industries.
Kurasiteku Use of Funds
The company will use the funding to strengthen its development framework and accelerate the development of next-generation AI agents using NoDB/NLIDB technology and MCP, enabling improved natural language data access and AI system integration.
About Kurasiteku
Kurasiteku develops AI solutions designed to automate administrative and documentation tasks for home-visit nursing stations. Its product, Hokan AI Ope, is an AI agent that supports a wide range of operational tasks, including receipt processing, insurance card input, instruction sheet management, report and care plan creation, and document transmission. Kurasiteku’s mission is to implement AI in ways that suit society and make care work easier and more fulfilling. Headquartered in Tokyo, Japan, the platform has already been deployed in more than 100 home-visit nursing stations.
Funding Details
Company: Kurashi Tech Inc.
Raised: Undisclosed
Round: Unknown
Funding Date: February 2026
Lead Investor: Rice Capital
Additional Investors:
Company Website: https://kteku.com/
Software Category: Healthcare AI / Nursing Operations Automation
Source: https://thebridge.jp/en/2026/02/kurasiteku-developer-of-home-visit-nursing-ai-hokan-ai-ope-secures-funding-from-rice-capital